Tourism convention begins today in TA

More than 30 countries and 200 presenters will participate.

By SHELLY PAZ
February 5, 2008 09:20
tourism biz 88 224

tourism biz 88 224. (photo credit: Ariel Jerozlimski)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

More than 30 countries and 200 presenters will participate in the 14th International Mediterranean Tourism Market convention, to be held February 5-6 at the Tel Aviv Fairgrounds. The convention will be open to the public free of charge each day starting at 3 p.m. Some 30 Israeli tourist companies will participate. Visitors will have the chance to win plane tickets, vacations in Greece, cruises, vacations in Israeli hotels and more, and beer and wine tasting will be offered, as well as musical and dance shows.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Cookie Settings